Search Within

Erica Simone Dayan

Formats
  1. Journal Article (7)
  2. Meeting Abstract (6)
Groups
  1. Department of Medicine (12)
  2. Genitourinary Oncology Service (12)
  3. Solid Tumor Oncology Division (12)
  4. Biostatistics Service (6)
  5. Epidemiology and Biostatistics (6)
  6. GME, Medicine (3)

More Groups

People
  1. Howard Scher (12)
  2. Michael Morris (6)
  3. Glenn Heller (5)
  4. Daniel Danila (4)
  5. Karen Autio (4)
  6. Niamh Keegan (3)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (3)
  4. 2020 (2)
  5. 2019 (1)
  6. 2018 (2)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Annals of Oncology (1)
  3. European Urology (1)
  4. European Urology Oncology (1)
  5. European Urology Open Science (1)
  6. JCO Oncology Practice (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. Elsevier BV (2)
  3. Elsevier Science, Inc. (2)
  4. Innovative Healthcare Institute (1)
  5. Lippincott Williams & Wilkins (1)
  6. Oxford University Press (1)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2, randomized, 3-arm study of abiraterone acetate and prednisone (AAP), AAP plus degarelix (AAP plus D), and degarelix (D) alone for patients (pts) with biochemically-recurrent prostate cancer (PC) following radical prostatectomy (RP)
    Meeting Abstract

    Autio, K. A.; Antonarakis, E. S.; Mayer, T. M.; Vaishampayan, U. N.; Shevrin, D. H.; Harrison, M. R.; Tagawa, S. T.; Milowsky, M. I.; Graff, J. N.; Beer, T. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A pilot study of a multimodal treatment paradigm to accelerate drug evaluations in early-stage metastatic prostate cancer
    Journal Article

    O'Shaughnessy, M. J.; McBride, S. M.; Vargas, H. A.; Touijer, K. A.; Morris, M. J.; Danila, D. C.; Laudone, V. P.; Bochner, B. H.; Sheinfeld, J.; Dayan, E. S.; more...
    Urology (2017)

    Fulltext@MSK | Save
  • Efficacy analysis of a phase III study of androgen deprivation therapy (ADT) +/- docetaxel (D) for men with biochemical relapse (BCR) after prostatectomy
    Meeting Abstract

    Morris, M. J.; Hilden, P.; Gleave, M. E.; Armstrong, A. J.; Carducci, M. A.; Saad, F.; Dayan, E. S.; Filipenko, J.; Acosta, I.; Heller, G.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save